PCSK9 Inhibitor improves outcomes for patients with peripheral artery disease

A new sub-analysis of the FOURIER clinical trial, however, now offers information on the safety and effectiveness of giving the PCSK9 inhibitor evolocumab on top of statin therapy to patients with peripheral artery disease. …read more

Source: EurekAlert

(Visited 2 times, 1 visits today)

Popular Posts